According to a press release from the Multidisciplinary Association for Psychedelic Studies Canada (MAPS Canada), Ethnobotany of Psychoactive Plants with Chris Kilham is a four-part miniseries that explores the human relationship with ayahuasca, kava, coca and cannabis.
Kilham has spent decades researching medicinal plants in more than 45 countries, investigating various medicines from different plants. MAPS Canada’s executive director Mark Haden had this to say about Kilham: He is one of the most charismatic speakers I have ever seen on stage.
This site is part of a series of MAPS websites in which over 50 scientists, clinicians, luminaries, researchers, shamans and experts give their views on the current psychedelic renaissance.
Psychedelics offer a very different model of recovery, said Haden, who began his career leading addiction treatment programs. Failing to get his employer to take psychedelic healing seriously, he decided to become self-employed and founded MAPS Canada in 2011.
MAPS Canada’s mission is to train psychotherapists so that they are qualified to do their jobs. We want to have a high standard because it’s exposed, Hayden said.
Psychedelic healing is slowly gaining importance in modern medicine. Haden is increasingly invited to lecture at medical schools. After all, they say they are evidence-based and we provide the evidence that they need to change their practices.
In 2017, MAPS received approval to conduct clinical trials of MDMA psychotherapy for people suffering from post-traumatic stress disorder (PTSD). Haden explained that of all the psychoactive substances, MDMA was chosen because it provides the gentlest and most supportive environment for people to deal with their unconscious issues.
Of the 103 study participants who received two to three sessions, 54% were free of PTSD after one to two months of follow-up. After 12 months’ follow-up, 68% no longer suffered from PTSD.
Haden said MAPS advocates a fully transformative model of healing, …where patients heal through a series of sessions and do not have to fall back on medication.
In an interview with the Sun, Dr. Charles Rayson, a professor at the University of Wisconsin-Madison, said: What psychedelics do when they work is give you a huge boost.
Rayson is working on a Phase 2 trial of psilocybin at the Osona Institute and hopes to get it approved for the treatment of major depression. He said one of the fascinating things about psychedelics is that the experiences often change people’s stories about themselves and the world for the better. Research shows that psychedelic experiences, when they occur in the right clinical context, dramatically alter people’s personal histories.
Haden thinks the cure will be determined by the big pharmaceutical companies, who stand to gain the most from someone taking their medicine every day for the rest of their lives. This financial agenda has led to this discussion about healing, which has nothing to do with healing. It’s essentially about symptom control.
According to Haden, support is the most important part of recovery for people with mental illness … and support is decreased by COVID, because people cannot go out together, and support is about contact with others.
Dr. Mary Bartram, director of mental health and addictions at the Mental Health Commission of Canada, said that before the pandemic, we knew that social bonds and a sense of belonging were important factors in good mental health.
A survey conducted in December 2020 by the Canadian Mental Health Research Agency found that one in four Canadians had been diagnosed with anxiety or depression. Bartram is not surprised.
We know from previous disasters and pandemics that the mental health consequences are usually long and complex and last for some time. The survey also found that 65% of Canadians are still highly resistant to VIDOC-19.
Bartram says that while humans are incredibly strong, she believes it’s too early to know everything about how a pandemic will affect mental health.
As for psychedelic therapy, Bartram says she sees an increasing role for it. …Emerging evidence suggests effectiveness for people who are not relieved by other trauma treatment approaches.
Haden stated that it would be preferable for MAPS Canada to become a national organization. We were originally in Vancouver, but then people from all over the country joined us.
The four-phase web series begins on the 23rd. February 2021 to raise awareness of the disease and funds for research and education through voluntary donations.
Main image : Mark Haden, Executive Director of MAPS Canada.